Developer docs
API playgroundTry for free, no card

Search company profiles

Regxia

Full company profile

uuid0027r68

Namestring
Regxia
Legal namestring
Regxia Inc.
Websiteurl
regxia.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Regxia Inc. is a privately held Canadian scientific and regulatory consulting firm founded in 2007 by Betty Cory and Lori de Munnik, headquartered in Vaughan, Ontario. The firm serves small and mid-sized pharmaceutical and biotechnology companies in Canada and the United States, providing end-to-end regulatory support across the product lifecycle — from pre-clinical development through clinical phases, CMC, submission, and post-marketing pharmacovigilance. Regxia's service portfolio is organized into three pillars: regulatory consulting (dossier compilation, scientific and strategic advice, CMC, and clinical regulatory support), ePublishing (eCTD compilation and lifecycle management, and XML Product Monograph preparation using a proprietary validated platform with over 15,000 e-submissions completed to date), and quality services (QA system development, Drug Establishment Licensing, GMP inspection management, pharmacovigilance system compliance, and safety reporting).

The company operates a platform-plus-services model, with two notable proprietary technology assets: a validated eCTD electronic submission system and a proprietary digital platform that transforms Word-based Product Monographs into Health Canada-conformant validated XML submissions, including viewer-friendly HTML output. Regxia also maintains a technology integration partnership with Court Square Group to deliver fit-for-purpose pharmacovigilance solutions for smaller pharma clients that lack enterprise-scale PV infrastructure. The firm has participated in Health Canada's XML PM pilot program and positions itself as offering Health Canada and FDA dual-jurisdiction expertise that larger Big Pharma-focused consultancies do not target.

Regxia generates revenue through customized professional services engagements — project-based or retainer — sold directly to clients in the Canadian and US pharma and biotech markets. Pricing is quote-based and not publicly disclosed. The firm markets primarily through content (the 'Regxia Review' blog), organic social media (LinkedIn, Facebook, Twitter), and industry events such as the CAPRA Pharmaceutical Symposium, and is led by a founder-owned management team of 11-50 employees with no external capital raised since founding.

Short descriptiontext

Regxia is a Canadian scientific and regulatory consulting firm serving small and mid-sized pharmaceutical and biotech companies in Canada and the US with regulatory strategy, eCTD submissions, XML Product Monograph preparation, quality assurance, and pharmacovigilance services.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVaughan, Canada
HQ citystring
Vaughan
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory affairs consulting, eCTD submission publishing, pharmaceutical ePublishing, pharmacovigilance services, dossier compilation management
Industry1 code
PRIMARYBPAEAPAB
Regulatory Compliance Management (RegTech)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Professional, Scientific, and Technical Services54
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Regulatory Consulting
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Regulatory Consulting Services
TypeProfessional Services
Description

Regxia provides scientific and regulatory consulting services including dossier compilation, scientific advice, CMC support, and clinical regulatory support to pharmaceutical and biotech companies. Services are customized to each client's needs.

regxia.com
2ePublishing Services
TypeProfessional Services
Description

Electronic submission publishing services including eCTD compilation and lifecycle management, XML Product Monograph preparation and validation, and adaptation of submissions for new markets.

regxia.com
3Quality and Pharmacovigilance Services
TypeProfessional Services
Description

Quality assurance system support, pharmacovigilance system management, periodic safety reports (PSUR, PBRER, PADER), promotional material reviews, and GVP self-inspections for small to mid-sized pharma companies.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Regxia is a scientific and regulatory consulting firm that delivers customized regulatory affairs, ePublishing, quality assurance, and pharmacovigilance services to small and mid-sized pharmaceutical and biotech companies seeking Health Canada and FDA market access. Its core offerings include dossier compilation and management, scientific and strategic consulting, CMC and clinical regulatory support, validated eCTD submission publishing, proprietary XML Product Monograph preparation, full quality assurance system development, and ongoing pharmacovigilance and safety reporting. Services are delivered by an in-house team of regulatory experts through direct consulting engagements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 15,000 e-submissions completed successfully using validated publishing systems
+1 more record
Product overview1 text field

Regxia is a scientific and regulatory consulting firm serving pharmaceutical and biotech industries with expertise in Canadian and US regulatory affairs. The company operates as a platform-plus-services model, offering core ePublishing services (eCTD submissions and XML Product Monographs), regulatory services (dossier compilation, scientific consulting, CMC, and clinical support), and quality services (quality assurance systems and pharmacovigilance). All services are delivered through their team of regulatory experts and leverage proprietary validated systems for electronic submissions. With over 15,000 e-submissions completed to date, the company provides end-to-end regulatory support from pre-clinical development through post-approval lifecycle management.

Product and service8 records
1eCTD Submission Services
CategoryElectronic Regulatory Publishing
Description

Electronic Common Technical Document (eCTD) submission services for regulatory submissions to Health Canada and the FDA, including initial builds of CTAs/INDs and NDSs/NDAs, lifecycle management, and takeover of existing e-dossiers, supported by a validated publishing system with over 15,000 submissions completed to date.

2XML Product Monograph Services
CategoryElectronic Regulatory Publishing
Description

Structured XML Product Monograph preparation, validation, and submission services using a proprietary digital platform that conforms to Health Canada's controlled vocabulary and structural requirements, transforming Word documents into validated XML PM submissions that clients can use without XML coding expertise.

3Dossier Compilation and Management
CategoryRegulatory Affairs Consulting
Description

Comprehensive regulatory submission management including eCTD compilation, adaptation for new markets, and review of CMC, nonclinical and clinical dossiers for pharmaceutical and biotech sponsors.

4Scientific and Strategic Consulting
CategoryRegulatory Affairs Consulting
Description

Strategic regulatory advice including gap analysis of dossiers, agency meeting support, and literature reviews for SRTD or 505(b)(2) applications, provided to pharmaceutical and biotech sponsors.

5Chemistry, Manufacturing, and Controls (CMC)
CategoryRegulatory Affairs Consulting
Description

Regulatory CMC consulting leveraging trusted relationships with agency evaluators to strategically position dossiers for lifecycle approval, supported by specific expertise in Chemistry and Manufacturing development and documentation for pharmaceuticals and biotech products.

6Clinical Regulatory Support
CategoryRegulatory Affairs Consulting
Description

Strategic clinical regulatory advice throughout the drug development process with integration of nonclinical, CMC, and clinical programs for pharmaceutical and biotech sponsors.

7Quality Assurance System
CategoryQuality Assurance Services
Description

Canadian Quality Services including SOP development, Drug Establishment Licensing coordination, Health Canada GMP inspection management, and ongoing compliance support, designed as an all-inclusive QA solution for small to mid-sized companies.

8Pharmacovigilance and Safety Reporting
CategoryPharmacovigilance Services
Description

Compliant pharmacovigilance system with SOPs, templates and timelines; periodic safety reports (PSUR, PBRER, PADER); promotional materials reviews; and GVP self-inspections for small to mid-sized pharma companies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Regxia partners with Court Square Group to provide integrated pharmacovigilance solutions for small and mid-sized pharma companies. The partnership combines Regxia's regulatory expertise with Court Square Group's PV technology platform, offering fit-for-purpose, affordable, and compliant pharmacovigilance systems that meet Health Canada and FDA requirements without requiring enterprise-level infrastructure.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Veeva provides cloud-based regulatory information management (Vault RIM) and content management platforms to life sciences companies. Not a direct consulting competitor, but its technology platforms increasingly automate submission management work that Regxia performs manually, representing a structural competitive threat.

TypeDirect peer
Description

PharmaLex is a regulatory and pharmacovigilance consulting firm serving pharma and biotech clients. Directly comparable to Regxia in providing dossier compilation, submission support, and quality compliance services, though with broader global geographic reach.

TypeBroad incumbent
Description

Parexel is a major global CRO with comprehensive regulatory affairs and submission services. Overlaps with Regxia's regulatory consulting offerings, but its full-service CRO model targets larger enterprise clients.

TypeBroad incumbent
Description

ICON plc is a global CRO providing regulatory, clinical, and laboratory services to pharma and biotech. Competes with Regxia in the regulatory consulting space, though positioned as a broad incumbent serving larger enterprise clients.

TypeRegional player
Description

PharmEng Technology is a Canadian pharmaceutical consulting firm providing regulatory affairs, validation, and quality services. Comparable to Regxia in scope and Canadian market focus, though operates primarily in GMP validation and engineering services.

TypeDirect peer
Description

ProPharma Group provides regulatory affairs, quality compliance, and pharmacovigilance consulting services to pharmaceutical, biotech, and medical device companies. Highly comparable to Regxia in its outsourced regulatory and quality services model targeting small and mid-sized life sciences companies.

TypeDirect peer
Description

Voisin Consulting provides regulatory affairs, clinical development, and quality compliance services to pharma and biotech. Comparable to Regxia as a specialized regulatory and quality consulting firm serving life sciences clients across multiple geographies.

8NAMSA
TypeDirect peer
Description

NAMSA provides regulatory, quality, and clinical research services to medical device and biologics manufacturers. Comparable to Regxia as an outsourced regulatory and quality consulting firm serving small and mid-sized life sciences companies.

TypeDirect peer
Description

Alacrita is a life sciences consulting firm offering regulatory strategy, clinical development, and commercial advisory to pharma and biotech. Comparable to Regxia in its specialized regulatory consulting model for small and mid-sized life sciences companies.

TypeBroad incumbent
Description

IQVIA is a large global CRO and life sciences services company with extensive regulatory consulting capabilities. Comparable as a competitor for regulatory services, though its scale and full-service CRO model position it as a broad incumbent rather than a direct specialist competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regxia

Pharmaceutical Regulatory Consultingregxia.com

Regxia is a Canadian scientific and regulatory consulting firm serving small and mid-sized pharmaceutical and biotech companies in Canada and the US with regulatory strategy, eCTD submissions, XML Product Monograph preparation, quality assurance, and pharmacovigilance services.

What Regxia does

Regxia Inc. is a privately held Canadian scientific and regulatory consulting firm founded in 2007 by Betty Cory and Lori de Munnik, headquartered in Vaughan, Ontario. The firm serves small and mid-sized pharmaceutical and biotechnology companies in Canada and the United States, providing end-to-end regulatory support across the product lifecycle — from pre-clinical development through clinical phases, CMC, submission, and post-marketing pharmacovigilance. Regxia's service portfolio is organized into three pillars: regulatory consulting (dossier compilation, scientific and strategic advice, CMC, and clinical regulatory support), ePublishing (eCTD compilation and lifecycle management, and XML Product Monograph preparation using a proprietary validated platform with over 15,000 e-submissions completed to date), and quality services (QA system development, Drug Establishment Licensing, GMP inspection management, pharmacovigilance system compliance, and safety reporting).

The company operates a platform-plus-services model, with two notable proprietary technology assets: a validated eCTD electronic submission system and a proprietary digital platform that transforms Word-based Product Monographs into Health Canada-conformant validated XML submissions, including viewer-friendly HTML output. Regxia also maintains a technology integration partnership with Court Square Group to deliver fit-for-purpose pharmacovigilance solutions for smaller pharma clients that lack enterprise-scale PV infrastructure. The firm has participated in Health Canada's XML PM pilot program and positions itself as offering Health Canada and FDA dual-jurisdiction expertise that larger Big Pharma-focused consultancies do not target.

Regxia generates revenue through customized professional services engagements — project-based or retainer — sold directly to clients in the Canadian and US pharma and biotech markets. Pricing is quote-based and not publicly disclosed. The firm markets primarily through content (the 'Regxia Review' blog), organic social media (LinkedIn, Facebook, Twitter), and industry events such as the CAPRA Pharmaceutical Symposium, and is led by a founder-owned management team of 11-50 employees with no external capital raised since founding.

Regxia firmographics

Firmographics
Name
Regxia
Legal name
Regxia Inc.
Website
https://regxia.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
Regxia is a Canadian scientific and regulatory consulting firm serving small and mid-sized pharmaceutical and biotech companies in Canada and the US with regulatory strategy, eCTD submissions, XML Product Monograph preparation, quality assurance, and pharmacovigilance services.
Ownership category
akta.pro rank

Regxia industry classification

Industry
Product category
Pharmaceutical Regulatory Consulting
NAICS
Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (54)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYBPAEAPAB
Regulatory Compliance Management (RegTech)

Keywords

  • Regulatory affairs consulting
  • ECTD submission publishing
  • Pharmaceutical ePublishing
  • Pharmacovigilance services
  • Dossier compilation management

Where Regxia is headquartered

Location

Headquarters

HQ city
Vaughan
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Regxia business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Regulatory Consulting Services: Regxia provides scientific and regulatory consulting services including dossier compilation, scientific advice, CMC support, and clinical regulatory support to pharmaceutical and biotech companies. Services are customized to each client's needs.
  2. ePublishing Services: Electronic submission publishing services including eCTD compilation and lifecycle management, XML Product Monograph preparation and validation, and adaptation of submissions for new markets.
  3. Quality and Pharmacovigilance Services: Quality assurance system support, pharmacovigilance system management, periodic safety reports (PSUR, PBRER, PADER), promotional material reviews, and GVP self-inspections for small to mid-sized pharma companies.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Regxia product offering

Product offering

Core offering

Regxia is a scientific and regulatory consulting firm that delivers customized regulatory affairs, ePublishing, quality assurance, and pharmacovigilance services to small and mid-sized pharmaceutical and biotech companies seeking Health Canada and FDA market access. Its core offerings include dossier compilation and management, scientific and strategic consulting, CMC and clinical regulatory support, validated eCTD submission publishing, proprietary XML Product Monograph preparation, full quality assurance system development, and ongoing pharmacovigilance and safety reporting. Services are delivered by an in-house team of regulatory experts through direct consulting engagements.

Product overview

Regxia is a scientific and regulatory consulting firm serving pharmaceutical and biotech industries with expertise in Canadian and US regulatory affairs. The company operates as a platform-plus-services model, offering core ePublishing services (eCTD submissions and XML Product Monographs), regulatory services (dossier compilation, scientific consulting, CMC, and clinical support), and quality services (quality assurance systems and pharmacovigilance). All services are delivered through their team of regulatory experts and leverage proprietary validated systems for electronic submissions. With over 15,000 e-submissions completed to date, the company provides end-to-end regulatory support from pre-clinical development through post-approval lifecycle management.

Differentiator

Problem solved

Functional benefit

Products and services

  • eCTD Submission Services Electronic Common Technical Document (eCTD) submission services for regulatory submissions to Health Canada and the FDA, including initial builds of CTAs/INDs and NDSs/NDAs, lifecycle management, and takeover of existing e-dossiers, supported by a validated publishing system with over 15,000 submissions completed to date.
  • XML Product Monograph Services Structured XML Product Monograph preparation, validation, and submission services using a proprietary digital platform that conforms to Health Canada's controlled vocabulary and structural requirements, transforming Word documents into validated XML PM submissions that clients can use without XML coding expertise.
  • Dossier Compilation and Management Comprehensive regulatory submission management including eCTD compilation, adaptation for new markets, and review of CMC, nonclinical and clinical dossiers for pharmaceutical and biotech sponsors.
  • Scientific and Strategic Consulting Strategic regulatory advice including gap analysis of dossiers, agency meeting support, and literature reviews for SRTD or 505(b)(2) applications, provided to pharmaceutical and biotech sponsors.
  • Chemistry, Manufacturing, and Controls (CMC) Regulatory CMC consulting leveraging trusted relationships with agency evaluators to strategically position dossiers for lifecycle approval, supported by specific expertise in Chemistry and Manufacturing development and documentation for pharmaceuticals and biotech products.
  • Clinical Regulatory Support Strategic clinical regulatory advice throughout the drug development process with integration of nonclinical, CMC, and clinical programs for pharmaceutical and biotech sponsors.
  • Quality Assurance System Canadian Quality Services including SOP development, Drug Establishment Licensing coordination, Health Canada GMP inspection management, and ongoing compliance support, designed as an all-inclusive QA solution for small to mid-sized companies.
  • Pharmacovigilance and Safety Reporting Compliant pharmacovigilance system with SOPs, templates and timelines; periodic safety reports (PSUR, PBRER, PADER); promotional materials reviews; and GVP self-inspections for small to mid-sized pharma companies.

Quantifiable outcome

  • Over 15,000 e-submissions completed successfully using validated publishing systems
  • +1 more outcomes

Companies that use Regxia

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Regxia technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Regxia partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Court Square GroupcoreTechnology or IntegrationRegxia partners with Court Square Group to provide integrated pharmacovigilance solutions for small and mid-sized pharma companies. The partnership combines Regxia's regulatory expertise with Court Square Group's PV technology platform, offering fit-for-purpose, affordable, and compliant pharmacovigilance systems that meet Health Canada and FDA requirements without requiring enterprise-level infrastructure.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regxia competitors and assessment

Company assessment

Emerging players

  • Veeva Systems: Veeva provides cloud-based regulatory information management (Vault RIM) and content management platforms to life sciences companies. Not a direct consulting competitor, but its technology platforms increasingly automate submission management work that Regxia performs manually, representing a structural competitive threat.

Direct peers

  • PharmaLex: PharmaLex is a regulatory and pharmacovigilance consulting firm serving pharma and biotech clients. Directly comparable to Regxia in providing dossier compilation, submission support, and quality compliance services, though with broader global geographic reach.
  • ProPharma Group: ProPharma Group provides regulatory affairs, quality compliance, and pharmacovigilance consulting services to pharmaceutical, biotech, and medical device companies. Highly comparable to Regxia in its outsourced regulatory and quality services model targeting small and mid-sized life sciences companies.
  • Voisin Consulting Life Sciences: Voisin Consulting provides regulatory affairs, clinical development, and quality compliance services to pharma and biotech. Comparable to Regxia as a specialized regulatory and quality consulting firm serving life sciences clients across multiple geographies.
  • NAMSA: NAMSA provides regulatory, quality, and clinical research services to medical device and biologics manufacturers. Comparable to Regxia as an outsourced regulatory and quality consulting firm serving small and mid-sized life sciences companies.
  • Alacrita: Alacrita is a life sciences consulting firm offering regulatory strategy, clinical development, and commercial advisory to pharma and biotech. Comparable to Regxia in its specialized regulatory consulting model for small and mid-sized life sciences companies.

Broad incumbents

  • Parexel International: Parexel is a major global CRO with comprehensive regulatory affairs and submission services. Overlaps with Regxia's regulatory consulting offerings, but its full-service CRO model targets larger enterprise clients.
  • ICON plc: ICON plc is a global CRO providing regulatory, clinical, and laboratory services to pharma and biotech. Competes with Regxia in the regulatory consulting space, though positioned as a broad incumbent serving larger enterprise clients.
  • IQVIA: IQVIA is a large global CRO and life sciences services company with extensive regulatory consulting capabilities. Comparable as a competitor for regulatory services, though its scale and full-service CRO model position it as a broad incumbent rather than a direct specialist competitor.

Regional players

  • PharmEng Technology: PharmEng Technology is a Canadian pharmaceutical consulting firm providing regulatory affairs, validation, and quality services. Comparable to Regxia in scope and Canadian market focus, though operates primarily in GMP validation and engineering services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Regxia social profiles

Digital presence

Regxia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regxia leadership team

Management profile

Number of profiles

Profiles6 records

Regxia funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regxia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regxia

What does Regxia do?

Regxia is a scientific and regulatory consulting firm that delivers customized regulatory affairs, ePublishing, quality assurance, and pharmacovigilance services to small and mid-sized pharmaceutical and biotech companies seeking Health Canada and FDA market access. Its core offerings include dossier compilation and management, scientific and strategic consulting, CMC and clinical regulatory support, validated eCTD submission publishing, proprietary XML Product Monograph preparation, full quality assurance system development, and ongoing pharmacovigilance and safety reporting. Services are delivered by an in-house team of regulatory experts through direct consulting engagements.

Is Regxia a public or private company?

Regxia is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Regxia founded?

Regxia was founded in 2007. It employs 1 to 10 people.

Where is Regxia based?

Regxia is headquartered in Vaughan, Canada, in the North America region.

How does Regxia make money?

Three revenue lines are on record. Regulatory Consulting Services are the primary driver. The others are ePublishing Services and quality and Pharmacovigilance Services.

Who are Regxia's main competitors?

Veeva Systems is listed as an emerging player. Direct peers are PharmaLex, ProPharma Group, Voisin Consulting Life Sciences, NAMSA and Alacrita. Broad incumbents are Parexel International, ICON plc and IQVIA. PharmEng Technology is listed as a regional player.

Does Regxia have an API?

No public API is recorded for Regxia.

What industry is Regxia in?

Regxia's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is BPAEAPAB, Regulatory Compliance Management (RegTech). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales